TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 52 filers reported holding TYRA BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,724,223 | -19.1% | 2,739,595 | 0.0% | 1.02% | -21.8% |
| Q2 2023 | $46,655,303 | -10.4% | 2,739,595 | -15.4% | 1.30% | -31.7% |
| Q1 2023 | $52,060,292 | +177.1% | 3,239,595 | +31.0% | 1.90% | +140.0% |
| Q4 2022 | $18,789,685 | -13.5% | 2,472,327 | 0.0% | 0.79% | -11.7% |
| Q3 2022 | $21,732,000 | +22.9% | 2,472,327 | 0.0% | 0.90% | +5.2% |
| Q2 2022 | $17,677,000 | -33.2% | 2,472,327 | 0.0% | 0.85% | -19.3% |
| Q1 2022 | $26,454,000 | +0.4% | 2,472,327 | +32.0% | 1.06% | +10.6% |
| Q4 2021 | $26,358,000 | -11.6% | 1,873,332 | +10.5% | 0.96% | -17.7% |
| Q3 2021 | $29,814,000 | – | 1,694,933 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $47,187,000 | 19.65% |
| Nextech Invest Ltd. | 2,518,582 | $26,949,000 | 7.69% |
| TCG Crossover Management, LLC | 896,418 | $9,592,000 | 3.85% |
| Boxer Capital, LLC | 6,448,359 | $68,997,000 | 3.55% |
| Fairmount Funds Management LLC | 1,284,990 | $13,749,000 | 3.25% |
| RA Capital Management | 7,236,454 | $77,430,000 | 1.69% |
| Frazier Life Sciences Management, L.P. | 1,327,665 | $14,206,000 | 1.21% |
| BVF INC/IL | 2,472,327 | $26,454,000 | 1.06% |
| Cormorant Asset Management, LP | 757,432 | $8,105,000 | 0.62% |
| Sio Capital Management, LLC | 111,033 | $1,188,000 | 0.39% |